- Home
- FOLD vs ALHC Comparison
FOLD vs ALHC Comparison
Compare FOLD & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOLD | ALHC |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FOLD | ALHC |
|---|---|---|
| Price | $14.30 | $21.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $26.11 | $22.13 |
| AVG Volume (30 Days) | ★ 7.8M | 3.1M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $598,704,000.00 | ★ $3,637,156,000.00 |
| Revenue This Year | $21.49 | $48.62 |
| Revenue Next Year | $18.46 | $33.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 21.28 | ★ 47.39 |
| 52 Week Low | $5.51 | $11.63 |
| 52 Week High | $14.38 | $23.87 |
Technical Indicators
Market Signals| Indicator | FOLD | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 79.26 | 47.31 |
| Support Level | $14.30 | $21.00 |
| Resistance Level | $14.31 | $23.33 |
| Average True Range (ATR) | 0.03 | 0.89 |
| MACD | -0.13 | -0.28 |
| Stochastic Oscillator | 35.00 | 33.25 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.